A detailed history of Vestmark Advisory Solutions, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 6,139 shares of VRTX stock, worth $2.51 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
6,139
Previous 6,113 0.43%
Holding current value
$2.51 Million
Previous $2.87 Million 0.35%
% of portfolio
0.12%
Previous 0.13%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$460.0 - $505.78 $11,960 - $13,150
26 Added 0.43%
6,139 $2.86 Million
Q2 2024

Aug 12, 2024

BUY
$392.81 - $485.53 $1.81 Million - $2.24 Million
4,610 Added 306.72%
6,113 $2.87 Million
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $815 - $892
-2 Reduced 0.13%
1,503 $628,000
Q4 2023

Feb 06, 2024

SELL
$343.0 - $410.68 $56,252 - $67,351
-164 Reduced 9.83%
1,505 $612,000
Q3 2023

Nov 06, 2023

SELL
$338.18 - $362.46 $5.18 Million - $5.56 Million
-15,332 Reduced 90.18%
1,669 $580,000
Q2 2023

Aug 07, 2023

SELL
$314.42 - $351.91 $68,857 - $77,068
-219 Reduced 1.27%
17,001 $5.98 Million
Q1 2023

May 09, 2023

SELL
$283.23 - $323.1 $207,890 - $237,155
-734 Reduced 4.09%
17,220 $5.43 Million
Q4 2022

Jan 20, 2023

SELL
$285.76 - $321.48 $58,295 - $65,581
-204 Reduced 1.12%
17,954 $0
Q3 2022

Nov 03, 2022

SELL
$273.83 - $305.53 $161,833 - $180,568
-591 Reduced 3.15%
18,158 $5.26 Million
Q2 2022

Aug 04, 2022

SELL
$234.96 - $292.55 $240,599 - $299,571
-1,024 Reduced 5.18%
18,749 $5.28 Million
Q1 2022

Apr 27, 2022

SELL
$221.42 - $260.97 $46,276 - $54,542
-209 Reduced 1.05%
19,773 $5.16 Million
Q4 2021

Jan 31, 2022

SELL
$177.01 - $223.45 $63,192 - $79,771
-357 Reduced 1.76%
19,982 $4.39 Million
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $72,556 - $81,196
-400 Reduced 1.93%
20,339 $3.69 Million
Q2 2021

Aug 09, 2021

BUY
$187.49 - $221.1 $224,425 - $264,656
1,197 Added 6.13%
20,739 $4.18 Million
Q1 2021

May 10, 2021

BUY
$207.02 - $241.31 $829,943 - $967,411
4,009 Added 25.81%
19,542 $4.2 Million
Q4 2020

Feb 04, 2021

BUY
$207.01 - $276.09 $354,401 - $472,666
1,712 Added 12.39%
15,533 $3.67 Million
Q3 2020

Oct 19, 2020

BUY
$255.65 - $303.1 $544,023 - $644,996
2,128 Added 18.2%
13,821 $3.76 Million
Q2 2020

Aug 13, 2020

BUY
$225.48 - $295.8 $184,217 - $241,668
817 Added 7.51%
11,693 $3.4 Million
Q1 2020

May 06, 2020

SELL
$199.77 - $247.81 $105,878 - $131,339
-530 Reduced 4.65%
10,876 $2.59 Million
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $39,843 - $53,514
-239 Reduced 2.05%
11,406 $2.5 Million
Q3 2019

Nov 05, 2019

SELL
$166.23 - $187.09 $51,365 - $57,810
-309 Reduced 2.58%
11,645 $1.97 Million
Q2 2019

Aug 20, 2019

BUY
$164.61 - $190.37 $15,967 - $18,465
97 Added 0.82%
11,954 $2.19 Million
Q1 2019

May 14, 2019

BUY
$163.73 - $194.7 $1.94 Million - $2.31 Million
11,857 New
11,857 $2.18 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Vestmark Advisory Solutions, Inc. Portfolio

Follow Vestmark Advisory Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.